source
- Aspo Plc reports managers' transactions on August 10, 2026Aspo Plc disclosed that its managers executed transactions on August 10, 2026, as recorded in a filing. The filing does not provide details about the nature, size, or parties involved in the trans…
- Regeneron backs $75M series A for antibody upstart InfinimmuneInfinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A headlined by Regeneron’s venture arm.Fierce Biotech · 20h ago↗ source
- ‘We are proud to be in the lead’: Vaderis lands $152M for phase 3 study in rare blood vessel disorder